Expression and cellular localization of the kallikrein-kinin system in human ocular tissues

Experimental Eye Research

Volumn 63, Issue 1, 1996, Pages 19-26

  Ma, Jian Xing ^a   Song, Qing ^b   Hatcher, Heather C ^a   Crouch, Rosalie K ^a   Chao, Lee ^b   Chao, Julie ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Diabetic retinopathy; Eye; In situ hybridization; Kallikrein; Kinin; Kinin receptor; Reverse transcriptiion and PCR

Indexed keywords

KALLIKREIN; KININ; RECEPTOR;

ARTICLE; EYE; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; KALLIKREIN KININ SYSTEM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0030198289     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1006/exer.1996.0087     Document Type: Article

References (37)

1. Bhoola, K. D., Figueroa, C. D. and Worthy, K. (1992). Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol. Rev. 44, 1-80.
2. Catanzaro, O. L., Pivetta, O. H., Zuccollo, A., Buzzalino, N. D., de Matos, D. G., Vila, S. B. and Perez, M. (1989). Studies on kallikrein-kinin system and enzymes activity in organs and urine from diabetic mice models. Adv. Exp. Biol. 247A, 593-7.
3. Chen, L-M, Song, Q., Chao L. and Chao, J. (1995). Cellular localization of tissue kallikrein and kallistatin mRNAs in human kidney. Kidney Int. 48, 690-7.
4. Chai, K. X., Chen, L-M., Chao, J. and Chao L. (1993). Kallistatin: a novel human serine proteinase inhibitor, molecular cloning, tissue distribution, and expression in Escherichia coli, J. Biol. Chem. 268, 24498-505.
5. Clements, J. A. (1989). The glandular kallikrein family of enzymes: tissue-specific expression and hormonal regulation. Endocrine Rev. 10, 393-419.
6. Danser, A. H. J., Van Den Dorpel, M. A., Deinum, J., Derkx, F. H. M., Franken, A. A. M., Peperkamp, E., de Jong, P. T. V. M. and Schalekamp, M. A. D. H. (1989). Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy. J. Clin. Endocrinol. Metab. 68, 160-7.
7. Deinum, J., Derkx, F. H. M., Danser, A. H. J. and Schalekamp, M. A. A. H. (1990). Identification and quantification of renin and prorenin in the bovine eye. Endocrinology 126, 1673-982.
8. El-Dahr, S. S. (1994). Development biology of the renal kallikrein-kinin system. Pediatric Nephrol. 8, 624-31.
9. Everett, A. D., Scott, J., Wilfong, N., Marino, B., Rosenkranz, R. P., Inagami, T. and Gomez, R. A. (1992). Renin and angiotensin expression during the evolution of diabetes. Hypertension 19, 70-8.
10. Farmer, S. G. (1992). Biochemical and molecular pharmacology of kinin receptors. Annu. Rev. Pharmacol. Toxicol. 32, 511-36.
11. Frank, R. (1991). On the pathogenesis of diabetic retinopathy. Ophthalmology. 98, 586-93.
12. Franken, A. A. M., Derkx, F. H. M., Schalekamp., M. A. D. H., Veld, A. J. M., van Rens, E. H. and de Jong, P. T. V. M. (1988). Association of high plasma prorenin with diabetic retinopathy. J. Hypertension 6 (Suppl. 4), S461-3.
13. Case, J. M., Monnot, C., Clauser, E. and Corvol, P. (1993). Co-expression of type 1 angiotensin II receptor (AT1R) and renin mRNA in juxtaglomerular cells of the rat kidney. Endocrinology 132, 2723-5.
14. Handa, H., Skurama, S., Nakagawa, S., Yasukouchi, T., Skamoto, W. and Izumi, H. (1989). Glandular kallikrein, renin and angiotensin converting enzyme of diabetic and hypertensive rats. Adv. Exp. Med. Biol. 247B, 443-8.
15. Harvey, J. N., Edmundson, A. W., Jaffa, A. A., Martin, L. L. and Mayfield, R. K. (1992). Renal excretion of kallikrein and eicosanoids in patients with Type 1 (insulin-dependent) diabetic mellitus. Relationship to glomerular and tubular function. Diabetologia 35, 857-62.
16. Igic, R. (1985). Kallikrein and kininase in ocular tissues. Exp. Eye Res. 41, 117-20.
17. Jaffa, Rashid, Z., Pratt, J., Ashford, A. and Bailey, G. S. (1984). A quantitative study of the levels of glandular kallikrein in normal and diabetic rats. Biochem. Med. 31, 42-6.
18. Jaffa, A. A., Miller, D. H., Bailey, G. S., Chao, J., Margolius, H. S. and Mayfield, R. K. (1987). Abnormal regulation of renal kallikrein in experimental diabetes, effects of insulin on prokallikrein synthesis and activation. J. Clin. Invest. 80, 1651-9.
19. Jaffa, A. A., Chai, K. X., Chao, J., Chao, L. and Mayfield, R. K. (1992). Effects of diabetes and insulin on expression of kallikrein and renin genes in the kidney. Kidney Int. 41, 789-95.
20. Kuznetsova, T. P., Chesnokova, B. B. and Paskhina, T. S. (1991). Activity of tissue and plasma kallikrein and level of their precursors in eye tissue structures and media of healthy rabbits. Voprosy Meditsinskoi Khimii 37, 79-82.
21. 2 receptor to chromosome 14q32. Genomics 23, 362-9.
22. Madrino, L. J. (1992). Current Hypotheses for the biochemical basis of diabetic retinopathy. Diabetic Care 15, 1892-901.
23. Mandel, P., Rodesch, J. and Mantz, J. M. (1973). The treatment of experimental radiation lesions by kallikrein. In Kininogenases 1. (Eds Haberland, G. L. Rohen, J. W.). Pp. 171-188, Schattauer; Stuttgart and New York.
24. Manto, A., Cotroneo, P., Porcelli, G., Errico, G. D., Marra, G., Magnani, P., Tilli, P., Greco, A. V. and Ghirlanda, G. (1993). Urinary kallikrein excretion in Type 1 (insulin-dependent) diabetic mellitus. Diabetologia 36, 423-7.
25. Margolius, H. S. (1989). Tissue kallikreins and kinins: regulation and roles in hypertensive and diabetic diseases. Ann. Rev. Pharmocol. Toxicol. 29, 343-64.
26. Margolius, H. S. (1995). Kallikreins and kinins, some unanswered questions about system characteristics and roles in human disease. Hypertension 26, 221-9.
27. Mayfield, R. K., Margolius, H. S., Levine, J. H., Wohltmann, H. J., Loadholt, C. B. and Colwell, H. A. (1984). Urinary kallikrein excretion in insulin-dependent diabetes mellitus and its relationship to glycemic control. J. Clin. Endocrinol. Metab. 59, 278-86.
28. Mayfield, R. K., Margolius, H. S., Bailey, G. S., Miller, D. H., Sens, D. A., Squires, J. and Namm, D. H. (1985). Urinary and renal tissue kallikrein in the streptozotocin-diabetic rat. Diabetes 34, 22-8.
29. Perris, A. D. and Whitfield, J. F. (1969). The mitogenic action of bradykinin on thymic lymphocytes and its dependence on calcium. Proc. Soc. Exp. Biol. Med. 130, 1198-201.
30. Regoli, D., Rhaleb, N-E., Drapeau, G. and Dion, S. (1990). Kinin receptor subtypes. J. Cardiovasc. Pharmacol. 15. S30-8.
31. Rixon, R. H., Whitfield, J. F. and Bayliss, J. (1971). The stimulation of mitotic activity in the thymus and bone marrow of rats by kallikrein. Horm. Metab. Res. 3, 279-84.
32. Sambrook, J., Fritsch, E. F. and Maniatis, T. (1989). Molecular Cloning, A Laboratory Manual 2nd edn, Cold Spring Harbor Laboratory Press: New York.
33. Schachter, M. (1980). Kallikreins (kininogenases) - a group of serine proteases with bioregulatory actions. Pharmacol. Rev. 31, 1-17.
34. Schunkert, H., Ingelfinger, J. R., Jacob, H., Jackson, B., Bouyounes, B. and Dzau, V. J. (1992). Reciprocal feedback regulation of kidney angiotensinogen and renin mRNA expressions by angiotensin II. Am. J. Physiol. 263, (5PT 1), pE863-9.
35. 2 receptor mRNAs in human kidney. Am. J. Physiol. in press.
36. 2 receptor cDNA in Chinese hamster lung CCL39 fibroblasts. Biochem. Biophys. Res. Commun. 188, 786-93.
37. Yasujima, M., Yoshida, K., Kanazawa, M., Kohzuki, M., Omata K., Watanabe, H., Hiwatari, M., Sato, T. and Abe, K. (1993). Urinary active kallikrein excretion and diabetic renal impairments in streptozotocin-treated rats. Tohoku J. Exp. Med. 171, 135-44.